Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patent Eligibility Restoration Act of 2025
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues relating to the the Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) (H.R. 3152) and Patent Eligibility Restoration Act (PERA) (S. 1546) patent legislation
Patent Eligibility Restoration Act of 2025
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2026 · third_quarter · Q3
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to competitive bidding Issues related to the National Defense Authorization Act (NDAA)
Source: Senate LDA
Issues relating to the the Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) (H.R. 3152) and Patent Eligibility Restoration Act (PERA) (S. 1546) patent legislation
Ensuring Patient Access to Critical Breakthrough Products Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare
Ensuring Patient Access to Critical Breakthrough Products Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare
Ensuring Patient Access to Critical Breakthrough Products Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare Issues related to competitive bidding
Patent Eligibility Restoration Act of 2025
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues relating to the the Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) (H.R. 3152) and Patent Eligibility Restoration Act (PERA) (S. 1546) patent legislation
Patent Eligibility Restoration Act of 2025
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues relating to the the Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) (H.R. 3152) and Patent Eligibility Restoration Act (PERA) (S. 1546) patent legislation
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare Issues related to competitive bidding
Medical Device Electronic Labeling Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to competitive bidding Issues related to the National Defense Authorization Act (NDAA)
Medical Device Electronic Labeling Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding
Medical Device Electronic Labeling Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding Issues related to the National Defense Authorization Act (NDAA)
Medical Device Recall Improvement Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding
Medical Device Recall Improvement Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding Issues related to the National Defense Authorization Act (NDAA)
Medical Device Recall Improvement Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding Issues related to the National Defense Authorization Act (NDAA)
Medical Device Recall Improvement Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding
Ensuring Patient Access to Critical Breakthrough Products Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare
Ensuring Patient Access to Critical Breakthrough Products Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
VALID Act of 2023
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program
VALID Act of 2023
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding
VALID Act of 2023
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act
VALID Act of 2023
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act
Medical Device Electronic Labeling Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act
Medical Device Electronic Labeling Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding
Medical Device Electronic Labeling Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act
Medical Device Electronic Labeling Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program
Medical Device Recall Improvement Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act
Medical Device Recall Improvement Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act
Medical Device Recall Improvement Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding
Medical Device Recall Improvement Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act
Medical Device Recall Improvement Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding
Medical Device Recall Improvement Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
VALID Act of 2023
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program
VALID Act of 2023
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to privacy legislation Issues related to the use of Artificial Intelligence
VALID Act of 2023
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to PFAS Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to privacy legislation Issues related to the use of Artificial Intelligence
VALID Act of 2023
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues relating to CMS expansion of prior authorization requirements for medical procedures
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
VALID Act of 2023
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to PFAS Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy
VALID Act of 2023
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to PFAS Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to privacy legislation
VALID Act of 2023
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues relating to FDA Covid-19 Response Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to PFAS Chemical regulation
VALID Act of 2021
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues related to H.R. 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act Issues relating to FDA Covid-19 Response Issues relating to the medical product supply chain Issues relating to S. 3799, PREVENT Pandemics Act Issues related to CURES 2.0 Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the Valid Act of 2021 - H.R. 4128/S.2209 Issues related to cyber security including H.R. 7084/ S. 3983, PATCH Act
PATCH Act of 2022
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues related to H.R. 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act Issues relating to FDA Covid-19 Response Issues relating to the medical product supply chain Issues relating to S. 3799, PREVENT Pandemics Act Issues related to CURES 2.0 Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the Valid Act of 2021 - H.R. 4128/S.2209 Issues related to cyber security including H.R. 7084/ S. 3983, PATCH Act
Food and Drug Amendments of 2022
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues related to H.R. 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act Issues relating to FDA Covid-19 Response Issues relating to the medical product supply chain Issues relating to S. 3799, PREVENT Pandemics Act Issues related to CURES 2.0 Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the Valid Act of 2021 - H.R. 4128/S.2209 Issues related to cyber security including H.R. 7084/ S. 3983, PATCH Act
VALID Act of 2021
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues related to H.R. 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act Issues relating to FDA Covid-19 Response Issues relating to the medical product supply chain Issues relating to S. 3799, PREVENT Pandemics Act Issues related to CURES 2.0 Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the Valid Act of 2021 - H.R. 4128/S.2209 Issues related to cyber security including H.R. 7084/ S. 3983, PATCH Act
PREVENT Pandemics Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues related to H.R. 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act Issues relating to FDA Covid-19 Response Issues relating to the medical product supply chain Issues relating to S. 3799, PREVENT Pandemics Act Issues related to CURES 2.0 Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the Valid Act of 2021 - H.R. 4128/S.2209 Issues related to cyber security including H.R. 7084/ S. 3983, PATCH Act
PATCH Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues related to H.R. 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act Issues relating to FDA Covid-19 Response Issues relating to the medical product supply chain Issues relating to S. 3799, PREVENT Pandemics Act Issues related to CURES 2.0 Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the Valid Act of 2021 - H.R. 4128/S.2209 Issues related to cyber security including H.R. 7084/ S. 3983, PATCH Act
FDASLA Act of 2022
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA implementation Issues related to H.R. 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act Issues relating to FDA Covid-19 Response Issues relating to the medical product supply chain Issues relating to S. 3799, PREVENT Pandemics Act Issues related to CURES 2.0 Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the Valid Act of 2021 - H.R. 4128/S.2209 Issues related to cyber security including H.R. 7084/ S. 3983, PATCH Act
VALID Act of 2021
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
VALID Act of 2021
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
Food and Drug Amendments of 2022
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
Food and Drug Amendments of 2022
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
VALID Act of 2021
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
VALID Act of 2021
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
PREVENT Pandemics Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
PREVENT Pandemics Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
FDASLA Act of 2022
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
FDASLA Act of 2022
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) Program
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare Issues related to competitive bidding
Issues related to global trade and tariffs Issues related to United States-Mexico-Canada Agreement (USMCA)
Issues relating to the the Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) (H.R. 3152) and Patent Eligibility Restoration Act (PERA) (S. 1546) patent legislation
Issues related to appropriations and user fee funding for the Food and Drug Administration
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2026 · second_quarter · Q2
Issues relating to the the Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) (H.R. 3152) and Patent Eligibility Restoration Act (PERA) (S. 1546) patent legislation
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) Program
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding Issues related to the National Defense Authorization Act (NDAA)
Issues related to global trade and tariffs Issues related to United States-Mexico-Canada Agreement (USMCA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2026 · first_quarter · Q1
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) Program
Issues related to R&D tax credit, bonus depreciation, and interest deductability
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding
Issues related to global trade and tariffs Issues related to United States-Mexico-Canada Agreement (USMCA)
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare
Issues relating to the STRONGER Patents Act and Section 101 reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2025 · fourth_quarter · Q4
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare
Issues related to R&D tax credit, bonus depreciation, and interest deductability
Issues related to global trade and tariffs Issues related to United States-Mexico-Canada Agreement (USMCA)
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2025 · third_quarter · Q3
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare
Issues related to R&D tax credit, bonus depreciation, and interest deductability
Issues related to global trade and tariffs Issues related to United States-Mexico-Canada Agreement (USMCA)
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2025 · second_quarter · Q2
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) Program
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2025 · first_quarter · Q1
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2024 · fourth_quarter · Q4
Issues related to MDUFA implementation Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2024 · third_quarter · Q3
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2024 · second_quarter · Q2
Issues related to R&D Tax Credit
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2024 · first_quarter · Q1
Issues related to MDUFA implementation Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to PFAS Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to privacy legislation Issues related to the use of Artificial Intelligence
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2023 · fourth_quarter · Q4
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues related to MDUFA implementation Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to PFAS Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to privacy legislation
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2023 · third_quarter · Q3
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues related to MDUFA implementation Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to PFAS Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2023 · second_quarter · Q2
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues related to R&D Tax Credit
Issues related to MDUFA implementation Issues relating to FDA Covid-19 Response Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to PFAS Chemical regulation
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2023 · first_quarter · Q1
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues relating to CMS expansion of prior authorization requirements for medical procedures
Issues related to R&D Tax Credit Issues related to R&D expense amortization
Issues relating to the America COMPETES Act Issues relating to the United States Innovation and Competition Act (USICA)
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2022 · fourth_quarter · Q4
Issues related to R&D Tax Credit
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues relating to the America COMPETES Act, Issues relating to the United States Innovation and Competition Act (USICA)
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2022 · third_quarter · Q3
Issues relating to the America COMPETES Act, Issues relating to the United States Innovation and Competition Act (USICA)
Issues related to IGNITE America Innovation Act, Issues related to R&D Tax Credit
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2022 · second_quarter · Q2
Issues relating to the America COMPETES Act, Issues relating to the United States Innovation and Competition Act (USICA)
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Issues relating to the Medical Device User Fee and Modernization Act, Issues relating to FDA Covid-19 Response, Issues relating to the supply chain for medical products, Issues relating to the Build Back Better Plan, Issues relating to the PREVENT Pandemics Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2022 · first_quarter · Q1
Tax proposals to provide liquidity for startups (IGNITE Act)
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues relating to the America COMPETES Act, Issues relating to the United States Innovation and Competition Act (USICA)
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2021 · fourth_quarter · Q4
Issues relating to the Medical Device User Fee and Modernization Act, Issues relating to FDA Covid-19 Response, Issues relating to the supply chain for medical products, Issues relating to the Build Back Better Plan
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2021 · third_quarter · Q3
Issues relating to the STRONGER Patents Act and Section 101 reform
Tax proposals to provide liquidity for startups (IGNITE Act)
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2021 · second_quarter · Q2
Issues relating to the Medical Device User Fee and Modernization Act, Issues relating to FDA Covid-19 Response, Issues relating to the supply chain for medical products, Issues relating to the American Rescue Plan
Tax proposals to provide liquidity for startups (IGNITE Act)
Issues relating to the STRONGER Patents Act and Section 101 reform
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2021 · first_quarter · Q1
Issues relating to the Medical Device User Fee and Modernization Act, Issues relating to FDA Covid-19 Response, Issues relating to the supply chain for medical products, Issues relating to the American Rescue Plan
Tax proposals to provide liquidity for startups (IGNITE Act)
Issues relating to the STRONGER Patents Act and Section 101 reform
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2020 · fourth_quarter · Q4
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Tax solutions for COVID-19 relief
Issues relating to the Patent Reform Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2020 · third_quarter · Q3
Issues relating to Reimbursement of Medical Devices, The CARES Act
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Tax solutions for COVID-19 relief
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2020 · second_quarter · Q2
Issues relating to Reimbursement of Medical Devices, The CARES Act
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Tax solutions for COVID-19 relief
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2020 · first_quarter · Q1
Issues relating to Reimbursement of Medical Devices, The CARES Act
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues related to the Medical Device Tax
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2019 · fourth_quarter · Q4
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues related to the Medical Device Tax
Issues relating to the Patent Reform Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2019 · third_quarter · Q3
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues relating to the Patent Reform Act
Issues relating to Reimbursement of Medical Devices
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2019 · second_quarter · Q2
Issues related to the Medical Device Tax
Issues relating to Reimbursement of Medical Devices
Issues relating to the Patent Reform Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2019 · first_quarter · Q1
Issues relating to Reimbursement of Medical Devices
Issues related to the Medical Device Tax
Issues relating to the Patent Reform Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2018 · fourth_quarter · Q4
Issues relating to the Patent Reform Act
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues related to the Medical Device Tax
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2018 · third_quarter · Q3
Issues relating to Reimbursement of Medical Devices
Issues related to the Medical Device Tax
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2018 · second_quarter · Q2
Issues related to the Medical Device Tax
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues relating to the Patent Reform Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2018 · first_quarter · Q1
Issues related to the Medical Device Tax
Issues relating to the Patent Reform Act
Issues relating to Reimbursement of Medical Devices
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2017 · fourth_quarter · Q4
Issues relating to Reimbursement of Medical Devices
Issues related to the Medical Device Tax
Issues relating to the Patent Reform Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2017 · third_quarter · Q3
Issues relating to the Patent Reform Act
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues relating to Reimbursement of Medical Devices
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2017 · second_quarter · Q2
Issues relating to Reimbursement of Medical Devices
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues related to the Medical Device Tax
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2017 · first_quarter · Q1
Issues relating to Reimbursement of Medical Devices
Issues relating to the Patent Reform Act
Issues related to the Medical Device Tax
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2016 · fourth_quarter · Q4
Issues related to the Medical Device Tax
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues relating to the Patent Reform Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2016 · third_quarter · Q3
Issues relating to Reimbursement of Medical Devices
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues related to the Medical Device Tax
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2016 · second_quarter · Q2
Issues relating to Reimbursement of Medical Devices
Issues related to the Medical Device Tax
Issues relating to the Patent Reform Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2016 · first_quarter · Q1
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues related to the Medical Device Tax
Issues relating to the Patent Reform Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2015 · fourth_quarter · Q4
Issues related to the Medical Device Tax
Issues relating to the Patent Reform Act
Issues relating to Medical Device user Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax.
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2015 · third_quarter · Q3
Issues related to the Medical Device Tax
Issues relating to Reimbursement of Medical Devices
Issues relating to the Patent Reform Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2015 · second_quarter · Q2
Issues relating to Reimbursement of Medical Devices
Issues relating to Medical Device user Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax.
Issues relating to the Patent Reform Act
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2015 · first_quarter · Q1
Issues relating to Medical Device user Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax.
Issues relating to Reimbursement of Medical Devices
Issues related to the Medical Device Tax
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2014 · fourth_quarter · Q4
Issues relating to Reimbursement of Medical Devices
Issues relating to Medical Device User Fee and Modernization Act, issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to comparative Effectiveness, issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues related to the Medical Device Tax
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2014 · third_quarter · Q3
Issues relating to Reimbursement of Medical Devices
Issues relating to the Patent Reform Act
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax.
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2014 · second_quarter · Q2
Issues related to the Medical Device Tax
Issues relating to Reimbursement of Medical Devices
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issue relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2014 · first_quarter · RA
Issue relating to the Patent Reform Act, Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issue relating to Physcian Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainshring, Issues relating to Medical Device Tax, Issues relating to Reimbursement of Medical Devices
Issue relating to the Patent Reform Act, Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issue relating to Physcian Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainshring, Issues relating to Medical Device Tax, Issues relating to Reimbursement of Medical Devices
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2014 · first_quarter · Q1
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physcian Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues related to the Medical Device Tax
Issues relating to Reimbursement of Medical Devices
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2013 · fourth_quarter · 4A
Issues related to the Medical Device Tax
Issues relating to Medical Device User Fee and Modernization Act, issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Issues relating to Reimbursement of Medical Devices
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to S 1717
Issues related to R&D tax credit, bonus depreciation, and interest deductability
Issues related to trade and tariffs Issues related to United States-Mexico-Canada Agreement (USMCA)
Issues related to appropriations and user fee funding for the Food and Drug Administration
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
Issues related to R&D tax credit
Issues related to trade and tariffs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues related to R&D Tax Credit
Issues relating to the STRONGER Patents Act and Section 101 reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues related to MDUFA implementation Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program
Issues related to R&D Tax Credit
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues related to MDUFA implementation Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to privacy legislation Issues related to the use of Artificial Intelligence
Issues relating to the STRONGER Patents Act and Section 101 reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues related to R&D Tax Credit
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues related to R&D Tax Credit
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues related to R&D Tax Credit
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act/ TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues related to MDUFA implementation Issues related to H.R. 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act Issues relating to FDA Covid-19 Response Issues relating to the medical product supply chain Issues relating to S. 3799, PREVENT Pandemics Act Issues related to CURES 2.0 Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the Valid Act of 2021 - H.R. 4128/S.2209 Issues related to cyber security including H.R. 7084/ S. 3983, PATCH Act
Issues relating to the STRONGER Patents Act and Section 101 reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues relating to the STRONGER Patents Act and Section 101 reform
Issues related to MDUFA Reauthorization, Issues related to HR 7667, Food and Drug Amendments of 2022, Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, Issues relating to FDA Covid-19 Response, Issues relating to the medical product supply chain, Issues relating to the Build Back Better Plan, Issues relating to S. 3799, PREVENT Pandemics Act, Issues related to CURES 2.0, Issues related to medical device sterilization, Issues related to the Valid Act of 2021 - HR 4128/S.2209
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Tax proposals to provide liquidity for startups (IGNITE Act)
Issues relating to the STRONGER Patents Act and Section 101 reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues relating to the Medical Device User Fee and Modernization Act, Issues relating to FDA Covid-19 Response, Issues relating to the supply chain for medical products, Issues relating to the Build Back Better Plan, Issues relating to the PREVENT Pandemics Act
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Tax proposals to provide liquidity for startups (IGNITE Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues relating to the Medical Device User Fee and Modernization Act, Issues relating to FDA Covid-19 Response, Issues relating to the supply chain for medical products, Issues relating to the Build Back Better Plan
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues relating to the Reimbursement of Medical Devices, coverage for FDA Breakthrough products and the Medicare Coverage for Innovative Technologies rule, Issues relating to CMS expansion of prior authorization requirements for medical procedures
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Issues relating to Reimbursement of Medical Devices, The CARES Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to the Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to the Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to the Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Reimbursement of Medical Devices
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues related to the Medical Device Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Reimbursement of Medical Devices
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to the Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Reimbursement of Medical Devices
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues related to the Medical Device Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to the Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Reimbursement of Medical Devices
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to the Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Reimbursement of Medical Devices
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Reimbursement of Medical Devices
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to Medical Device user Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues related to the Medical Device Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to the Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to the Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues related to the Medical Device Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issues relating to the Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issue relating to the Patent Reform Act, Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issue relating to Physcian Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainshring, Issues relating to Medical Device Tax, Issues relating to Reimbursement of Medical Devices
Issue relating to the Patent Reform Act, Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issue relating to Physcian Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainshring, Issues relating to Medical Device Tax, Issues relating to Reimbursement of Medical Devices
Issues relating to the Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE
Issue relating to the Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE